Xenon Pharmaceuticals Inc. - COM (XENE)

Q3 2018 13F Holders as of 9/30/2018

Type / Class
Equity / COM
Number of holders
59
Total Shares
17.7M
Shares change
+8.58M
Total reported value, excl. options
$234M
Value change
+$115M
Put/Call ratio
0
Number of buys
36
Number of sells
-22
Price
$13.20
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.